{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T08:00:23Z","timestamp":1773820823427,"version":"3.50.1"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Depressive disorders represent a major contributor to the global burden of disease, with persistently rising prevalence rates posing significant challenges to individual quality of life and public health systems. Existing first-line medications such as selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) typically require 2\u20134\u00a0weeks to take effect, with complete remission rates below 60%. Approximately one-third of patients discontinue treatment within 90\u00a0days due to adverse reactions including gastrointestinal discomfort, weight changes, or sexual dysfunction. Consequently, exploring interventions with faster onset and improved tolerability holds significant clinical importance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search of seven databases\u2014PubMed, Embase, Web of Science, Cochrane CENTRAL, CNKI, AMED, and Scopus\u2014identified randomised controlled trials (RCTs) and mechanism studies published between 2010 and 2025. A qualitative synthesis method analysed clinical efficacy and adverse reactions, integrating evidence from metabolomics, epigenetics, and network pharmacology. Botanical drug identification was performed in accordance with ConPhYMP guidelines, with all species names validated taxonomically against the Medicinal Plant Names Services (MPNS) and Plants of the World Online (POWO) databases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twenty-one RCTs (n = 2,766) and three mechanistic studies were included. Findings indicated that Xiaoyao Formula\n                      <jats:italic>may<\/jats:italic>\n                      exert earlier effects than SSRIs (descriptive trend: 1\u20132\u00a0weeks vs. 2\u20134\u00a0weeks), with comparable or\n                      <jats:italic>preliminary evidence of<\/jats:italic>\n                      superior remission rates and lower residual symptom incidence. Adverse reactions, particularly gastrointestinal discomfort and sleep disturbances, were significantly reduced. No serious adverse events, hepatotoxicity, or clinically significant drug interactions were reported across the evidence base, although systematic adverse event reporting was incomplete in earlier trials. Mechanistic studies\n                      <jats:italic>suggest<\/jats:italic>\n                      a hypothetical sequential pathway\u2014\u2018inflammation precedes neuroplasticity recovery\u2019\u2014involving downregulation of IL-6 and NLRP3 inflammasome, reduced methylation of the BDNF promoter, and activation of the PI3K-Akt pathway. A three-dimensional Q-marker system (based on UPLC-HRMS) comprising baicalin, ferulic acid, and glycyrrhizic acid provides a preliminary framework for quantifying the metabolite-mechanism-efficacy relationship and may serve as a candidate criterion for cross-centre consistency testing.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Existing evidence preliminarily supports potential advantages of Xiaoyao Formula in treating depressive disorders, including possibly earlier onset of action, good tolerability, and potential additional benefits in female subgroups. However, given limitations such as small sample sizes, short intervention durations (6\u201312\u00a0weeks), and predominantly combination therapy rather than monotherapy comparisons, these conclusions should be regarded as suggestive or indicative findings rather than definitive efficacy. Long-term efficacy and generalisability across populations require further validation. Future studies should conduct multicentre, large-sample clinical trials with \u226524-week follow-up, incorporating wearable digital phenotyping technologies to confirm its application value in precision psychiatry.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1718573","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:59:10Z","timestamp":1773817150000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Inflammation\u2013neurotrophin synergy of Xiao-yao-san-type botanical drug formulations in depressive disorders: a qualitative synthesis of recent human studies with taxonomic and compositional characterisation"],"prefix":"10.3389","volume":"17","author":[{"given":"Liu","family":"Han","sequence":"first","affiliation":[{"name":"Department of Behavioural Science and Health, University College London","place":["London, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qun","family":"Liang","sequence":"additional","affiliation":[{"name":"First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine","place":["Harbin, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7874","DOI":"10.1021\/jm5006463","article-title":"Polypharmacology: challenges and opportunities in drug discovery","volume":"57","author":"Anighoro","year":"2014","journal-title":"J. Med. Chem."},{"key":"B2","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1142\/S0192415X05003296","article-title":"Effects of chai hu (Radix bupleuri) containing formulation on plasma beta-endorphin, epinephrine and dopamine on patients","volume":"33","author":"Chen","year":"2005","journal-title":"Am. J. Chin. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e00241","DOI":"10.14309\/ctg.0000000000000241","article-title":"An botanical drug formulation of jiawei xiaoyao for the treatment of functional dyspepsia: a multicenter, randomized, placebo-controlled, clinical trial","volume":"11","author":"Chen","year":"2020","journal-title":"Clin. Transl. Gastroenterology"},{"key":"B4","volume-title":"Pharmacopoeia of the People's Republic of China","year":"2020"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"357","DOI":"10.4088\/JCP.v63n0414","article-title":"Prevalence of sexual dysfunction among newer antidepressants","volume":"63","author":"Clayton","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","first-page":"406960","DOI":"10.1155\/2014\/406960","article-title":"Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension","volume":"2014","author":"Dinh","year":"2014","journal-title":"BioMed Res. Int."},{"key":"B8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1067\/mcp.2002.126409","article-title":"Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivo","volume":"72","author":"Dresser","year":"2002","journal-title":"Clin. Pharmacol. and Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"16739","DOI":"10.3748\/wjg.v20.i44.16739","article-title":"Xiaoyao pill for treatment of functional dyspepsia in perimenopausal women with depression","volume":"20","author":"Du","year":"2014","journal-title":"World J. Gastroenterology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A neurotrophic model for stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","first-page":"155660","DOI":"10.1016\/j.phymed.2024.155660","article-title":"Xiaoyao pills, a Chinese patent medicine, treats mild and moderate depression: a randomized clinical trial combined with DNA methylation analysis","volume":"130","author":"Fan","year":"2024","journal-title":"Phytomedicine"},{"key":"B12","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1186\/s12903-024-04318-2","article-title":"Efficacy of danzhixiaoyao tablets combined with methylcobalamin tablets in the treatment of burning mouth syndrome: an open-label, randomized controlled trial","volume":"24","author":"Gao","year":"2024","journal-title":"BMC Oral Health"},{"key":"B13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1001\/jamapsychiatry.2015.2653","article-title":"Association of age at menopause and duration of reproductive period with depression after menopause: a systematic review and meta-analysis","volume":"73","author":"Georgakis","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurology, Neurosurg. Psychiatry"},{"key":"B15","doi-asserted-by":"publisher","first-page":"953205","DOI":"10.3389\/fphar.2022.953205","article-title":"Best practice in the chemical characterisation of extracts used in pharmacological and toxicological research\u2014The ConPhyMP\u2014Guidelines","volume":"13","author":"Heinrich","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B16","first-page":"387","article-title":"IL-6 enhances the nuclear translocation of DNA cytosine-5-methyltransferase 1 (DNMT1) via phosphorylation of the nuclear localization sequence by the AKT kinase","volume":"4","author":"Hodge","year":"2007","journal-title":"Cancer Genomics and Proteomics"},{"key":"B17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1471-2105-13-86","article-title":"DNA methylation arrays as surrogate measures of cell mixture distribution","volume":"13","author":"Houseman","year":"2012","journal-title":"BMC Bioinforma."},{"key":"B18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jtcms.2023.12.002","article-title":"Modified xiaoyao powder for postpartum depression: a systematic review and meta-analysis","volume":"11","author":"Hu","year":"2024","journal-title":"J. Traditional Chin. Med. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1186\/gb-2014-15-2-r31","article-title":"Accounting for cellular heterogeneity is critical in epigenome-wide association studies","volume":"15","author":"Jaffe","year":"2014","journal-title":"Genome Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.bbi.2019.06.038","article-title":"Modifying effects of depression on the association between BDNF methylation and prognosis of acute coronary syndrome","volume":"81","author":"Kim","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"B21","first-page":"197","article-title":"Effect of danzhi xiaoyao powder on neuro-immuno-endocrine system in patients with depression","volume":"27","author":"Li","year":"2007","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"B22","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1089\/acm.2008.0010","article-title":"The beneficial effects of the botanical drug medicine free and easy wanderer plus (FEWP) and fluoxetine on post-stroke depression","volume":"14","author":"Li","year":"2008","journal-title":"J. Altern. Complementary Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"115032","DOI":"10.1016\/j.jep.2022.115032","article-title":"Clinical efficacy of shugan granule in the treatment of mixed anxiety-depressive disorder: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"290","author":"Li","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.19852\/j.cnki.jtcm.20231110.003","article-title":"Effectiveness and safety of jiawei xiaoyao pill in the treatment of premenstrual syndrome (liver depression, spleen deficiency, and blood-heat syndrome): a multi-center, randomized, placebo-controlled trial","volume":"44","author":"Li","year":"2024","journal-title":"J. Traditional Chin. Med."},{"key":"B25","first-page":"280","article-title":"Dan zhi xiao yao powders in the treatment of patients with hypertension complicated with depression","volume":"28","author":"Liu","year":"2008","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"B26","doi-asserted-by":"publisher","first-page":"312","DOI":"10.19439\/j.sjos.2019.03.018","article-title":"Clinical evaluation of modified xiaoyao pill on the treatment of oral lichen planus patients with anxiety or depression","volume":"28","author":"Liu","year":"2019","journal-title":"Shanghai Kou Qiang Yi Xue"},{"key":"B27","first-page":"212","article-title":"Clinical observation on effect of danzhi xiaoyao powder in treating depression","volume":"26","author":"Luo","year":"2006","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"B28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1089\/jwh.2018.27099.mensocrec","article-title":"Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations","volume":"28","author":"Maki","year":"2019","journal-title":"J. Women's Health"},{"key":"B29","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.bbi.2021.02.021","article-title":"Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up","volume":"94","author":"Mazza","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"B30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"B31","volume-title":"Medicinal plant names services","year":"2024"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.archoralbio.2013.04.004","article-title":"Oral lichen planus: focus on etiopathogenesis","volume":"58","author":"Payeras","year":"2013","journal-title":"Archives Oral Biol."},{"key":"B33","volume-title":"Plants of the world online","year":"2024"},{"key":"B34","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1365-2362.2006.01591.x","article-title":"Menstrual cycle symptoms are associated with changes in low-grade inflammation","volume":"36","author":"Puder","year":"2006","journal-title":"Eur. J. Clin. Investigation"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.jpsychires.2011.06.004","article-title":"Meta-analysis of randomized controlled trials to assess the effectiveness and safety of free and easy wanderer plus, a polyherbal preparation for depressive disorders","volume":"45","author":"Qin","year":"2011","journal-title":"J. Psychiatric Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jep.2013.12.022","article-title":"What is in a name? The need for accurate scientific nomenclature for plants","volume":"152","author":"Rivera","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"B37","first-page":"41","article-title":"Antidepressant adherence: are patients taking their medications?","volume":"9","author":"Sansone","year":"2012","journal-title":"Innovations Clin. Neurosci."},{"key":"B38","volume-title":"Best practice in research \u2013 recommendations for reporting on plant-derived products","year":"2025"},{"key":"B39","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"B40","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0278-6915(93)90080-I","article-title":"Glycyrrhizic acid in liquorice\u2014evaluation of health hazard","volume":"31","author":"Stormer","year":"1993","journal-title":"Food Chem. Toxicol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"410","DOI":"10.19852\/j.cnki.jtcm.2019.03.014","article-title":"Jiawei xiaoyao capsule treatment for mild to moderate major depression with anxiety symptoms: a randomized, double-blind, double-dummy, controlled, multicenter, parallel-treatment trial","volume":"39","author":"Su","year":"2019","journal-title":"J. Traditional Chin. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1080\/14786419.2020.1747823","article-title":"Simultaneous determination of multiple components in modified xiaoyao san by ultra-performance liquid chromatography","volume":"35","author":"Su","year":"2021","journal-title":"Nat. Prod. Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.archoralbio.2009.05.007","article-title":"Salivary levels of IL-1\u03b2, IL-6, IL-8, and TNF-\u03b1 in patients with burning mouth syndrome","volume":"54","author":"Suh","year":"2009","journal-title":"Archives Oral Biol."},{"key":"B44","first-page":"1023","article-title":"Effects of acupuncture combined Chinese materia medica for tonifying shen and soothing gan on the anxiety and depression of patients with in vitro fertilization and embryo transplantation and on the treatment outcomes","volume":"32","author":"Sun","year":"2012","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"B45","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/gutjnl-2012-303857","article-title":"Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia","volume":"63","author":"Vanheel","year":"2014","journal-title":"Gut"},{"key":"B46","unstructured":"Depressive disorder (depression): key facts\n          \n          \n          2023"},{"key":"B57","doi-asserted-by":"publisher","first-page":"590788","DOI":"10.3389\/fmicb.2020.590788","article-title":"The genus Pachyma (syn. Wolfiporia) reinstated and species clarification of the cultivated medicinal mushroom \u201cFuling\u201d in China","volume":"11","author":"Wu","year":"2020","journal-title":"Front. Microbiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"153602","DOI":"10.1016\/j.phymed.2021.153602","article-title":"Assessment of the inhibition potential of radix Bupleuri-derived saikosaponins against cytochrome P450 enzymes","volume":"88","author":"Xin","year":"2021","journal-title":"Phytomedicine"},{"key":"B48","first-page":"642","article-title":"Comparative study of modified xiaoyao pill combining amitriptyline on therapeutic effect and compliance in treating patients with depression","volume":"27","author":"Yang","year":"2007","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"B49","doi-asserted-by":"publisher","first-page":"343","DOI":"10.19852\/j.cnki.jtcm.2023.02.005","article-title":"Effectiveness of xiaoyao capsule on sleep disorders and mood disturbance in patients in recovery from coronavirus disease 2019: a randomized controlled trial","volume":"43","author":"Yang","year":"2023","journal-title":"J. Traditional Chin. Med."},{"key":"B50","first-page":"1257","article-title":"Clinical observation on treatment of major depressive disorder by paroxetine combined with chaihu xiaoyao mixture","volume":"30","author":"Yi","year":"2010","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"B51","first-page":"318","article-title":"Study on modified xiaoyao decoction combining clomipramine treating depression","volume":"27","author":"Yu","year":"2007","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"B52","first-page":"202","article-title":"Clinical study on effect of fluoxetine combined with Chinese medicine or Tibetan drugs in treating senile depression in plateau district","volume":"26","author":"Zhang","year":"2006","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"B53","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jpsychires.2005.06.002","article-title":"Adjunctive botanical drug medicine with carbamazepine for bipolar disorders: a double-blind, randomized, placebo-controlled study","volume":"41","author":"Zhang","year":"","journal-title":"J. Psychiatric Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.jpsychires.2006.08.002","article-title":"The beneficial effects of the botanical drug medicine free and easy wanderer plus (FEWP) for mood disorders: double-blind, placebo-controlled studies","volume":"41","author":"Zhang","year":"","journal-title":"J. Psychiatric Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"931636","DOI":"10.1155\/2012\/931636","article-title":"Chinese herbal formula xiao yao san for treatment of depression: a systematic review of randomized controlled trials","volume":"2012","author":"Zhang","year":"2012","journal-title":"Evidence-Based Complementary Altern. Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"273","DOI":"10.13422\/j.cnki.syfjx.20221229","article-title":"Xiaoyaosan in treatment of depression: a review","volume":"28","author":"Zhang","year":"2022","journal-title":"Chin. J. Exp. Traditional Med. Formulae"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1718573\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:59:16Z","timestamp":1773817156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1718573\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":57,"alternative-id":["10.3389\/fphar.2026.1718573"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1718573","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"article-number":"1718573"}}